Suppr超能文献

基于结构的虚拟筛选中晶体结构的研究:蛋白激酶抑制剂。

Investigation of Crystal Structures in Structure-Based Virtual Screening for Protein Kinase Inhibitors.

机构信息

Laboratory of Molecular Design and Drug Discovery, School of Science , China Pharmaceutical University , 639 Longmian Avenue , Nanjing 211198 , China.

State Key Laboratory of Natural Medicines , China Pharmaceutical University , 24 Tongjiaxiang , Nanjing 210009 , China.

出版信息

J Chem Inf Model. 2019 Dec 23;59(12):5244-5262. doi: 10.1021/acs.jcim.9b00684. Epub 2019 Nov 15.

Abstract

Protein kinases are important drug targets in several therapeutic areas ,and structure-based virtual screening (SBVS) is an important strategy in discovering lead compounds for kinase targets. However, there are multiple crystal structures available for each target, and determining which one is the most favorable is a key step in molecular docking for SBVS due to the ligand induce-fit effect. This work aimed to find the most desirable crystal structures for molecular docking by a comprehensive analysis of the protein kinase database which covers 190 different kinases from all eight main kinase families. Through an integrated self-docking and cross-docking evaluation, 86 targets were eventually evaluated on a total of 2608 crystal structures. Results showed that molecular docking has great capability in reproducing conformation of crystallized ligands and for each target, the most favorable crystal structure was selected, and the AGC family outperformed the other family targets based on RMSD comparison. In addition, RMSD values, GlideScore, and corresponding bioactivity data were compared and demonstrated certain relationships. This work provides great convenience for researchers to directly select the optimal crystal structure in SBVS-based kinase drug design and further validates the effectiveness of molecular docking in drug discovery.

摘要

蛋白激酶是多个治疗领域的重要药物靶点,基于结构的虚拟筛选(SBVS)是发现激酶靶点先导化合物的重要策略。然而,对于每个靶点,都有多个晶体结构可供选择,由于配体诱导契合效应,确定哪个晶体结构最有利是 SBVS 分子对接的关键步骤。本研究旨在通过对涵盖来自八个主要激酶家族的 190 种不同激酶的蛋白激酶数据库进行全面分析,找到最适合分子对接的晶体结构。通过整合的自对接和交叉对接评估,最终对总共 2608 个晶体结构中的 86 个靶标进行了评估。结果表明,分子对接在重现结晶配体构象方面具有很大的能力,对于每个靶标,都选择了最有利的晶体结构,并且基于 RMSD 比较,AGC 家族的表现优于其他家族靶标。此外,RMSD 值、GlideScore 和相应的生物活性数据进行了比较,并证明了它们之间存在一定的关系。这项工作为研究人员在基于 SBVS 的激酶药物设计中直接选择最佳晶体结构提供了极大的便利,进一步验证了分子对接在药物发现中的有效性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验